Filing Details
- Accession Number:
- 0001225208-11-026738
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-20 17:44:47
- Reporting Period:
- 2011-08-15
- Filing Date:
- 2011-12-20
- Accepted Time:
- 2011-12-20 17:44:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
810509 | Neoprobe Corp | NEOP | Surgical & Medical Instruments & Apparatus (3841) | 311080091 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1195757 | C David Bupp | 425 Metro Place North Suite 300 Dublin OH 43017 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-15 | 300,000 | $0.00 | 2,900,328 | No | 4 | A | Direct | |
Common Stock | Disposition | 2011-12-16 | 42,186 | $2.45 | 2,758,142 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-12-19 | 7,814 | $2.54 | 2,750,328 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 129,056 | Indirect | By 401(k) |
Common Stock | 213,746 | Indirect | By Spouse |
Footnotes
- The sales in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Bupp on September 13, 2011.
- Price represents a weighted average of the sale price. Shares were sold at prices ranging from $2.38 to $2.65. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares sold at each separate price.
- Price represents a weighted average of the sale price. Shares were sold at prices ranging from $2.53 to $2.55. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares sold at each separate price.